API Manufacturing

In addition to Wockhardt's development and finished dosage form capabilities, we boast a state-of-the-art cGMP compliant API manufacturing facility approved by the USFDA and UKMHRA.

Key Manufacturing Capabilities & Attributes:

• State-of-the-art facility to manufacture sterile cephalosporins API's
• Flexibility to manufacture high value - low volume products and high volume products
• Multipurpose plant which can manufacture several products at a time handling high pressure, high temperature (up to 250 degrees Celsius) and low temperature (up to -70 degrees Celsius) reactions
• Macrolide production
• DMF's filed during last three years is 30+
• API's developed in last three years is 50+

Key Research Capabilities & Attributes:

• R&D team consisting 70+ scientists of which 20+ scientists are PhD's
• API R&D team is supported by a dedicated analytical group comprising 40 scientists, of which 5 are Ph.Ds.
• 30 years of API process research experience
• Excellent History of precise and timely implementation of projects
• Development of solutions to generate robust API processes.
• Equilibrium between low cost and high value added work
• API's developed to date is 150+